VERSABANK PRICES OFFERING OF COMMON SHARES

In This Article:

The Base Shelf Prospectus is accessible, and the Final Prospectus Supplement will be accessible within two business days, on SEDAR+ and on EDGAR

LONDON, ON, Dec. 16, 2024 /CNW/ - VersaBank (Nasdaq:VBNK; TSX:VBNK) (the "Bank") today announced the pricing of its previously announced public offering of 5,660,378 common shares (the "Offering") at a price to the public of US$13.25 per share. The gross proceeds from the Offering, before underwriting discounts and offering costs, are expected to be US$75,000,009.

VersaBank logo (CNW Group/VersaBank)
VersaBank logo (CNW Group/VersaBank)

The Bank has also granted the Underwriters (as defined below) an over-allotment option to purchase up to an additional 15% of the common shares to be sold pursuant to the Offering (the "Over-Allotment Option"). The Over-Allotment Option is exercisable for a period of 30 days from the date of the final prospectus supplement (the "Final Prospectus Supplement") relating to the Offering.

The Bank expects that the net proceeds from the Offering will be used for general banking purposes and will qualify as Common Equity Tier 1 capital for the Bank.

The closing of the Offering is subject to a number of customary closing conditions, including the listing of the common shares on the Nasdaq and TSX, and any required approvals of each exchange, and is expected to occur on or about December 18, 2024. Raymond James & Associates, Inc. is acting as the sole bookrunning manager, and Keefe, Bruyette & Woods, A Stifel Company, and Roth Canada, Inc. are acting as co-managers for the Offering (collectively, the "Underwriters").

No securities regulatory authority has either approved or disapproved the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.

The Bank has filed a preliminary prospectus supplement dated December 16, 2024 (the "Preliminary Prospectus Supplement"), and will file the Final Prospectus Supplement, to its short form base shelf prospectus dated November 22, 2024 (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces and territories of Canada except Quebec. The Preliminary Prospectus Supplement has also been filed, and the Final Prospectus Supplement will be filed, with the U.S. Securities and Exchange Commission (the "SEC") as a supplement to the Bank's registration statement on Form F-10 (the "Registration Statement") under the U.S./Canada Multijurisdictional Disclosure System. The prospectus supplements, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Offering. Access to the Base Shelf Prospectus, the Final Prospectus Supplement, and any amendments to the documents will be provided in accordance with securities legislation relating to procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment thereto. The Base Shelf Prospectus and the Preliminary Prospectus Supplement are, and the Final Prospectus Supplement will be (within two business days of the date hereof), accessible on SEDAR+ at www.sedarplus.ca, and copies of the Registration Statement and the Preliminary Prospectus Supplement are, and the Final Prospectus Supplement will be, accessible on EDGAR at www.sec.gov. An electronic or paper copy of the Base Shelf Prospectus, the Registration Statement, the Final Prospectus Supplement (when filed), and any amendment to the documents may be obtained without charge, from Raymond James & Associates, Inc., Attention: Equity Syndicate – 880 Carillon Parkway, St. Petersburg, Florida. Telephone: (800) 248-8863 or e-mail: prospectus@raymondjames.com by providing the contact with an email address or address, as applicable.  Prospective investors should read the Base Shelf Prospectus, the Registration Statement and the Final Prospectus Supplement (when filed) before making an investment decision.